Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)

被引:0
作者
Daojun Mo
Dana Sue Hardin
Eva Marie Erfurth
Shlomo Melmed
机构
[1] Eli Lilly and Company,Lilly Research Laboratories
[2] Lilly Corporate Center,Department of Endocrinology
[3] Skånes University Hospital,Pituitary Center, Department of Medicine
[4] Cedars-Sinai Medical Center,undefined
来源
Pituitary | 2014年 / 17卷
关键词
Growth hormone deficiency; Mortality; Morbidity; GH treatment; HypoCCS; SAGhE;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:477 / 485
页数:8
相关论文
共 137 条
[1]  
Carel JC(2012)Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study J Clin Endocrinol Metab 97 416-425
[2]  
Ecosse E(2012)Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study J Clin Endocrinol Metab 97 E213-E217
[3]  
Landier F(2012)Long-term surveillance of growth hormone therapy J Clin Endocrinol Metab 97 68-72
[4]  
Meguellati-Hakkas D(2012)Long-term therapy with growth hormone: bringing sagacity to SAGhE J Clin Endocrinol Metab 97 81-83
[5]  
Kaguelidou F(2009)Changing patterns of the adult growth hormone deficiency diagnosis documented in a decade-long global surveillance database J Clin Endocrinol Metab 94 392-399
[6]  
Rey G(2011)Assessment of primary cancers in GH-treated adult hypopituitary patients: an analysis from the Hypopituitary Control and Complications Study Eur J Endocrinol 165 217-223
[7]  
Coste J(2011)Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing’s disease or non-functioning pituitary adenoma J Clin Endocrinol Metab 95 630-638
[8]  
Sävendahl L(2013)Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS Eur J Endocrinol 168 565-573
[9]  
Maes M(2010)Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement J Clin Endocrinol Metab 95 74-81
[10]  
Albertsson-Wikland K(2011)Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis J Clin Endocrinol Metab 96 2255-2261